The Hidden Sovereign Husband

2. The First Crack

Chapter 2: The First Crack

Samuel was done by nine in the morning.

Two duffel bags by the door, the apartment stripped of anything that was actually his, which wasn’t much. He stood in the living room for a moment, not out of sentimentality but out of habit. He’d spent a lot of nights in that room quietly going through Abby’s contracts, finding problems before they became crises, fixing things she never knew needed fixing.

He transferred the apartment title into her name before he left. The three million would sit in an account he’d probably never look at. He wasn’t interested in her money. He never had been.

His phone vibrated once on the way out.

Contingency protocols initiated. Thorne Labs audit flagged. European assets on standby. Awaiting directive, Sovereign.

He typed back without breaking stride: Monitor only. No major moves yet.

The door clicked shut behind him. Another chapter closed.

Across the city, Abigail walked into the Montgomery Pharma conference room the way she always did, like the meeting had already started without her and needed to catch up. Her team straightened as she took her seat. Lucas was already at the front, slides loaded, looking pleased with himself.

“Thorne deal closes in six days,” she said, skipping the pleasantries. “I want every risk on the table.”

Lucas pulled up the numbers. “Solid across the board. The neuro-regenerative compound is already moving pre-market. This could be our biggest play yet.”

Abby nodded. But last night kept needling at her. Samuel’s parting comment, delivered so quietly on his way out the door. Falsified stability data. Account 47-B. She’d dismissed it by the time she reached her car. He had no access to anything beyond public filings. He barely had a professional footprint to speak of.

Still. The certainty in his voice.

“Pull the audit summary,” she said.

The finance director was halfway through his third sentence when his phone buzzed. Then someone else’s. Then the whole table seemed to light up at once.

“What is it?” Abby asked.

The director’s face had gone pale. “Anonymous tip just hit the FDA whistleblower portal. References subsidiary account 47-B. Alleges manipulated stability data on the neuro compound. They’re requesting immediate verification.”

Nobody spoke.

Lucas recovered first. “Competitor sabotage. Classic move. Our internal audits are clean, this goes nowhere.”

But Abby wasn’t listening to Lucas. She was hearing Samuel’s voice again, word for word, the way he’d said it without even turning around. You don’t have long.

“Full independent review,” she said. “End of day. Nobody touches the closing timeline until I say so.”

That evening, her mother’s house was lit up like a celebration, because as far as Victoria Montgomery was concerned, it was one.

“To freedom,” Nathan announced, raising his glass with the satisfaction of someone who’d personally achieved something. “Five years of that man dragging along in your shadow, Abby. Good riddance to him.”

Victoria clinked her glass approvingly, diamonds catching the chandelier light. “I never trusted him. All that quiet. A man with nothing to say usually has nothing worth saying. You deserve someone who can actually stand beside you at the top. Someone like Lucas.”

Abigail smiled at the right moments and said the right things. But the family’s celebration felt louder than the occasion called for, and her mind kept drifting back to the office. The FDA inquiry had gone semi-public in an industry newsletter by late afternoon. Two minor investors had already pulled out. Stock closed down 6.5%.

Nathan was scrolling his phone, grinning. “Heard he moved out this morning with two bags. Two. That’s all he had after five years. Honestly kind of sad.”

Her phone lit up with a message from Lucas. Handled the audit. Minor discrepancies found but being corrected. Deal still on track.

She replied quickly and set the phone face down. Minor discrepancies. The exact phrase people used when they didn’t want to say what they’d actually found.

How had Samuel known?

Downtown, in a corner booth of a quiet café that didn’t advertise itself, Samuel sat across from Elias, his longtime steward. The old man was in his seventies, unhurried, pouring tea with the same practiced care he’d shown for decades. He was one of perhaps four people alive who understood the full extent of what the Whitaker name actually meant.

“The contingency has begun as requested,” Elias said, without looking up from the teacups. “Montgomery Pharma will feel the pressure gradually. Nothing traceable back to you.”

“Keep it measured,” Samuel said. “She built that company with her own hands. I won’t take apart what she worked for unless they make it necessary.”

Elias glanced at him with the particular patience of someone who had watched this family for a very long time. “And Miss Montgomery herself?”

Samuel looked toward the window. The city outside was settling into its evening rhythm, lights coming on in layers. “We made different choices. That’s all it is.”

His secure phone buzzed against the table. The name on the screen stopped him for just a second. Dr. Olivia Sinclair. Lead researcher at Vantage Biotech, one of the few firms doing genuinely original work in regenerative medicine. He hadn’t heard from her in years.

Heard you might be stepping back into things. Curious timing with everything at Montgomery. Coffee sometime? Strictly professional.

A quiet smile crossed his face. The first one in a while.

Back at the estate, Victoria was mid-sentence about an upcoming industry gala when Abigail’s phone buzzed again. The stock dip had held. The FDA inquiry was gaining traction. And somewhere in the back of her mind, a door she thought she’d closed cleanly was refusing to stay shut.

For the first time since she’d slid those papers across the table, Abigail Montgomery felt something she hadn’t budgeted for. Doubt.